ABC Law Centers owner and managing partner, Jesse Reiter, is excited to commit to three more years of financing the Reiter HIE Research Fund. This fund supports the research of Dr. John Donald E. Barks, who is a professor in the Department of Pediatrics and the Director of the Division of Neonatal-Perinatal Medicine at the University of Michigan. Dr. Barks’ clinical and laboratory work is critical to the development of new treatments for newborns with hypoxic-ischemic encephalopathy (HIE).
Jesse Reiter (left) and Dr. John Barks (right) at C.S. Mott Children’s Hospital.
Hypoxic-ischemic encephalopathy (HIE) is brain damage caused by insufficient oxygenated blood flow to the brain during or near the time of labor and delivery. HIE can cause numerous health conditions, including cerebral palsy, seizure disorders, learning disabilities, motor disorders, sensory processing disorders, and others.
Currently, the main treatment modality for HIE is therapeutic hypothermia, in which newborns with HIE are cooled to about 91 degrees Fahrenheit for three days and then slowly re-warmed. Dr. Barks’ research was instrumental in establishing therapeutic hypothermia as a standard treatment for HIE, and he continues to further our knowledge of therapeutic hypothermia as a neuroprotective agent.
Additionally, Dr. Barks and his colleagues investigate the safety, effectiveness, benefits, and complications of therapeutic hypothermia. Their research includes comparing whole body cooling and selective head cooling, as well as determining the circumstances under which therapeutic hypothermia is most beneficial. Dr. Barks and his team also explore how to manage complications associated with HIE (e.g. seizures) in neonates undergoing treatment as well as combination therapies
Jesse has committed to continued support of the research done by Dr. Barks and colleagues in the upcoming years.
Interested in donating to the Reiter HIE Research Fund?
Please click here to make an online contribution.